DRUG · Mapped RxNorm record
Zidovudine
Normalized identity: zidovudine View linked drug · Find medicine records ·
Find other trials using this name
Clinical trial
Granulocyte-Macrophage Colony-Stimulating Factor and Zidovudine: A Phase I Study of Concurrent Administration in Patients With AIDS and Severe ARC
NCT00000711
Study summary
ClinicalTrials.govGranulocyte-Macrophage Colony-Stimulating Factor and Zidovudine: A Phase I Study of Concurrent Administration in Patients With AIDS and Severe ARC
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE1
Loading study purpose, treatment groups and outcomes…
View the complete registry record, eligibility and contacts at ClinicalTrials.gov
Drugs and interventions used in this trial
2 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DRUG · Mapped RxNorm record
Sargramostim
Normalized identity: sargramostim View linked drug · Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Advertisement
Conditions
HIV Infectionsunresolved
Cytopeniasunresolved
Interventions
ZidovudineDRUG · verified · RxNorm: zidovudine
SargramostimDRUG · verified · RxNorm: sargramostim
Sponsors & collaborators
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00000711 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.